Source: Annual Congress 2005 - Gene expression, receptors and markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Sanz-Ortega, J. Sanz-Espinera, S. Hernandez, M. Saez, F. Roig-Vázquez, A. Muñoz, J. Granda-Orive, L. Callol-Sánchez (Madrid, Spain). Loss of heterozygosity off the P16, P53 and APC gene in oral cavity exfoliate cytologic material among lung cancer patients. Eur Respir J 2005; 26: Suppl. 49, 2923

Member's Comments

No comment yet.

Related content which might interest you: Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004 Detection of k-ras mutations in cytologic specimen of lung cancer patients as predictive factor of targeted therapy Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 Clinical relevance of p53 and K-ras gene mutations in bronchial margins in surgically treated nonsmall cell lung cancer (NSCLC) patients Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Aberrant methylation of p16 tumour suppresor gene and DAP kinase in nonsmall cell lung carcinomas Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype Source: Eur Respir J 2014; 43: 872-883 Year: 2014 Is caveolin-1 lost as a tumor suppressor gene in lung carcinoma? Source: Annual Congress 2004 - Lung development and cancer Year: 2004 Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Her-2/neu expression in advanced non small cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 HER-2/neu overexpression in patients with lung carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53 Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 HER-2/neu expression in bioptic and surgical samples of non small cell lung carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002